Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Hartinger

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Chemical Communications (Cambridge, England)|September 10, 2019
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activityShahida Parveen, Muhammad Hanif, Euphemia Leung, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2021
Incorporation of β-Alanine in Cu(II) ATCUN Peptide Complexes Increases ROS Levels, DNA Cleavage and Antiproliferative ActivityJulian Heinrich, Karolina Bossak-Ahmad, Mie Riisom, et al.
Inorganic Chemistry|October 2, 2020
Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived LigandsMichał Łomzik, Muhammad Hanif, Aleksandra Budniok, et al.
Chempluschem|January 22, 2020
Functionalization of Ruthenium(II)(η<sup>6</sup> -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical StudiesMuhammad Hanif, Samuel M Meier, Zenita Adhireksan, et al.
Inorganic Chemistry|November 9, 2018
From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer AgentsNelson Y S Lam, Dianna Truong, Hilke Burmeister, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 9, 2008
In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligandsIsabella Berger, Muhammad Hanif, Alexey A Nazarov, et al.
Chemical Science|January 9, 2018
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of actionMaria V Babak, Samuel M Meier, Kilian V M Huber, et al.
Journal of Medicinal Chemistry|January 28, 2009
Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activityMaria G Mendoza-Ferri, Christian G Hartinger, Marco A Mendoza, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2017
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For PlectinSamuel M Meier, Dominique Kreutz, Lilli Winter, et al.
Inorganic Chemistry|February 20, 2020
Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl<sub>2</sub> ComplexesDianna Truong, Matthew P Sullivan, Kelvin K H Tong, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Chemical Communications (Cambridge, England)|September 10, 2019
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activityShahida Parveen, Muhammad Hanif, Euphemia Leung, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2021
Incorporation of β-Alanine in Cu(II) ATCUN Peptide Complexes Increases ROS Levels, DNA Cleavage and Antiproliferative ActivityJulian Heinrich, Karolina Bossak-Ahmad, Mie Riisom, et al.
Inorganic Chemistry|October 2, 2020
Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived LigandsMichał Łomzik, Muhammad Hanif, Aleksandra Budniok, et al.
Chempluschem|January 22, 2020
Functionalization of Ruthenium(II)(η<sup>6</sup> -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical StudiesMuhammad Hanif, Samuel M Meier, Zenita Adhireksan, et al.
Inorganic Chemistry|November 9, 2018
From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer AgentsNelson Y S Lam, Dianna Truong, Hilke Burmeister, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 9, 2008
In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligandsIsabella Berger, Muhammad Hanif, Alexey A Nazarov, et al.
Chemical Science|January 9, 2018
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of actionMaria V Babak, Samuel M Meier, Kilian V M Huber, et al.
Journal of Medicinal Chemistry|January 28, 2009
Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activityMaria G Mendoza-Ferri, Christian G Hartinger, Marco A Mendoza, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2017
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For PlectinSamuel M Meier, Dominique Kreutz, Lilli Winter, et al.
Inorganic Chemistry|February 20, 2020
Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl<sub>2</sub> ComplexesDianna Truong, Matthew P Sullivan, Kelvin K H Tong, et al.
Pageof 19